OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,085 | +16.3% | 492,881 | -14.9% | 0.03% | +23.8% |
| Q2 2023 | $5,230 | +161.9% | 579,309 | +0.6% | 0.02% | +133.3% |
| Q1 2023 | $1,997 | +41.7% | 575,900 | 0.0% | 0.01% | +28.6% |
| Q4 2022 | $1,409 | -99.9% | 575,900 | +0.5% | 0.01% | -22.2% |
| Q3 2022 | $1,580,000 | -16.7% | 572,977 | +22.9% | 0.01% | -10.0% |
| Q2 2022 | $1,897,000 | +287.9% | 466,166 | +305.1% | 0.01% | +400.0% |
| Q1 2022 | $489,000 | -48.0% | 115,076 | +14.4% | 0.00% | -50.0% |
| Q4 2021 | $940,000 | – | 100,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |